Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease

ClinicalTrials.gov ID: NCT03036150

Public ClinicalTrials.gov record NCT03036150. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03036150
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
4,304 participants

Conditions and interventions

Interventions

  • Dapagliflozin Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 1, 2017
Primary completion
Jun 11, 2020
Completion
Jun 11, 2020
Last update posted
Jul 6, 2021

2017 – 2020

United States locations

U.S. sites
55
U.S. states
22
U.S. cities
49
Facility City State ZIP Site status
Research Site Birmingham Alabama 35233
Research Site Hawaiian Gardens California 90716
Research Site Lomita California 90717
Research Site Los Angeles California 90022
Research Site Palo Alto California 94304
Research Site San Dimas California 91773
Research Site San Ramon California 94582
Research Site Vista California 92083
Research Site Aurora Colorado 80045
Research Site Denver Colorado 80246
Research Site Boynton Beach Florida 33435
Research Site Boynton Beach Florida 33472
Research Site Jacksonville Florida 32224
Research Site Miami Florida 33015
Research Site Miami Florida 33144
Research Site Miami Florida 33165
Research Site Miami Lakes Florida 33014
Research Site Naples Florida 34102
Research Site New Port Richey Florida 34652
Research Site Atlanta Georgia 30342-1797
Research Site Augusta Georgia 30904
Research Site Chicago Illinois 60643
Research Site Iowa City Iowa 52242
Research Site Topeka Kansas 66606
Research Site Wichita Kansas 67214
Research Site Metairie Louisiana 70006
Research Site Boston Massachusetts 02111
Research Site Detroit Michigan 48202
Research Site Flint Michigan 48504
Research Site Duluth Minnesota 55805
Research Site Omaha Nebraska 68105
Research Site Albany New York 12208
Research Site Asheville North Carolina 28801
Research Site Charlotte North Carolina 28207
Research Site Hickory North Carolina 28601
Research Site New Bern North Carolina 28562
Research Site Winston-Salem North Carolina 27103
Research Site Cincinnati Ohio 45219
Research Site Maumee Ohio 43537
Research Site Jersey Shore Pennsylvania 17740
Research Site Philadelphia Pennsylvania 19104
Research Site Greer South Carolina 29651
Research Site Kingsport Tennessee 37660
Research Site Nashville Tennessee 37232
Research Site El Paso Texas 79935
Research Site Fort Worth Texas 76116
Research Site Fort Worth Texas 76117
Research Site Fort Worth Texas 76164
Research Site Houston Texas 77004
Research Site Houston Texas 77030
Research Site Odessa Texas 79761
Research Site Burke Virginia 22015
Research Site Manassas Virginia 20110
Research Site Newport News Virginia 23606
Research Site Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 335 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03036150, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 6, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03036150 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →